FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2015/08/006124 [Registered on: 20/08/2015] Trial Registered Retrospectively
Last Modified On: 03/08/2015
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Surgical/Anesthesia 
Study Design  Randomized, Parallel Group, Active Controlled Trial 
Public Title of Study   comparison between dexamethasone and dexmedetomidine as an adjunct to ropivacaine in post operative shoulder surgery 
Scientific Title of Study   A randomised double blind study comparing dexmedetomidine with dexamethasone as an adjunct to ropivacaine in ultrasound guided interscalene block for shoulder surgery 
Trial Acronym   
Secondary IDs if Any  
Secondary ID  Identifier 
nil  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Sukanya Mitra 
Designation  Professor 
Affiliation  Government Medical College and Hospital, Sector 32, Chandigarh. 
Address  Department of Anaesthesia and Intensive Care, Government Medical College and Hospital, Chandigarh.

Chandigarh
CHANDIGARH
160030
India 
Phone  9646121521  
Fax    
Email  drsmitra12@yahoo.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Sukanya Mitra 
Designation  Professor 
Affiliation  Government Medical College and Hospital, Sector 32, Chandigarh. 
Address  Department of Anaesthesia and Intensive Care, Government Medical College and Hospital, Chandigarh.

Chandigarh
CHANDIGARH
160030
India 
Phone  9646121521  
Fax    
Email  drsmitra12@yahoo.com  
 
Details of Contact Person
Public Query
 
Name  Dr Sukanya Mitra 
Designation  Professor 
Affiliation  Government Medical College and Hospital, Sector 32, Chandigarh. 
Address  Department of Anaesthesia and Intensive Care, Government Medical College and Hospital, Chandigarh.

Chandigarh
CHANDIGARH
160030
India 
Phone  9646121521  
Fax    
Email  drsmitra12@yahoo.com  
 
Source of Monetary or Material Support  
Government Medical College and Hospital, sector 32, chandigarh. 
 
Primary Sponsor  
Name  Government Medical College and Hospital 
Address  Department of Anaesthesia and Intensive Care, Government Medical and Hospital, Chandigarh. 
Type of Sponsor  Government medical college 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Sukanya Mitra  Government Medical College and Hospital, sector 32, chandigarh  department of Anaesthesia and Intensive Care,fifth floor, D Block,Government medical college and hospital , sector 32 , chandigarh
Chandigarh
CHANDIGARH 
9646121521

drsmitra12@yahoo.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
institutional ethics commitee ( GMCH Chandigarh )  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  healthy patients with ASA grade 1-2,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  group 1  ultrasound guided interscalene block with .5 % ropivacaine 20 ml containing dexamethasone ( 8 mg ) to a total of 22 ml 
Comparator Agent  group 2  ultrasound guided interscalene block with .5 % ropivacaine 20 ml with 2 ml of saline containing dexmedetomidine .5 mcg/kg to a total of 22 ml. 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  65.00 Year(s)
Gender  Both 
Details  1. ASA status 1-2
2. BMI - 18-30 kg/m2
3. Shoulder surgery such as rotator cuff repair, recurrent shoulder dislocations, acromioplasty, hemiarthroplasty and total shoulder replacement. 
 
ExclusionCriteria 
Details  1. patient refusing to give informed consent
2. history of relevant drug allergy
3. history of psychiatric illness, substance abuse
4. severe cardiovascular, respiratory, metabolic or neurologic disease
5. pregnancy and lactation
6. coagulopathy
7. contralateral phrenic nerve dysfunction
8. infection at planned injection site
9.patients receiving alpha 2 agonists for hypertensive disorders
10.patients on steroids 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   Sequentially numbered, sealed, opaque envelopes 
Blinding/Masking   Participant, Investigator and Outcome Assessor Blinded 
Primary Outcome  
Outcome  TimePoints 
duration of post-operative analgesia as measured ( in minutes ) by the time from the achievement of adequate sensory block till the first use of fentanyl bolus by PCA  o hour- time at which adequate sensory block is achieved
To time till the patient takes first dose of rescue analgesic( in 24 hours ) 
 
Secondary Outcome  
Outcome  TimePoints 
pain ratings over 24 hours on 0-100 VAS , total post-operative analgesic consumption, patient satisfaction and adverse effects.  2 hourly monitoring after 4 hours of nerve block upto 24 hours . 
 
Target Sample Size   Total Sample Size="60"
Sample Size from India="60" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 4 
Date of First Enrollment (India)   01/04/2015 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="2"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Open to Recruitment 
Publication Details    
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Brief Summary   This study is a randomised ,double blind, single centre trial comparing the efficacy of dexamethasone and dexmedetomidine for post operative analgesia and cumulative total analgesic consumption when administered under ultrasound guidance as an adjunct to ropivacaine in interscalene block.it will be done in a period of 2 years in ASA 1 patients. pain will be assessed on basis of VAS score. Two groups will be studied , group 1 using .5 % ropivacaine 20 ml containing dexamethasone ( 8 mg ) to a total of 22 ml. group 2 using .5 % ropivacaine 20 ml with 2 ml of saline containg dexmedetomidine .5 mcg/kg to a total of 22 ml. Primary outcome will see the duration of postoperative analgsia, in minutes by the time from the achievement of adequate sensory block till the first use of fentanyl bolus by PCA. Secondary outcome will measure pain ratings over 24 hour on 0-100 VAS ,total postoperative analgesic consumption ,patient satisfaction and adverse effects.  
Close